Cargando…
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
Features of the gut microbiota have been associated with several chronic diseases and longevity in preclinical models as well as in observational studies. Whether these relations underlie causal effects in humans remains to be established. We aimed to determine whether the gut microbiota influences...
Autores principales: | Gagnon, Eloi, Mitchell, Patricia L., Manikpurage, Hasanga D., Abner, Erik, Taba, Nele, Esko, Tõnu, Ghodsian, Nooshin, Thériault, Sébastien, Mathieu, Patrick, Arsenault, Benoit J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887809/ https://www.ncbi.nlm.nih.gov/pubmed/36717893 http://dx.doi.org/10.1186/s12967-022-03799-5 |
Ejemplares similares
-
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases
por: Gagnon, Eloi, et al.
Publicado: (2022) -
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Émilie, et al.
Publicado: (2022) -
Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study
por: Ghodsian, Nooshin, et al.
Publicado: (2021) -
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Emilie, et al.
Publicado: (2021) -
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
por: Ghodsian, Nooshin, et al.
Publicado: (2021)